Skip to content

Contact +44 (0) 20 7060 7474 email us

Medical Devices

Bausch & Lomb Incorporated Medical Equipment Company Report

Medical Device Company Analysis Covering Key Information Relating to Company Market Share by Sector and Country, Financial, SWOT and Value Chain Analysis

Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 312
ISBN Number not applicable
Product Code GMD00548

Price

£660.00
approximately: $999 | €737

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

This report is an essential source for data, analysis and strategic insight into this company. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines company's business structure and operations, history and products, and provides an analysis of its key revenue lines. It inspects the company's strategy, both in terms of its value chain positioning and strategic strengths and weaknesses.

Scope

  • Revenues for the markets and sub-sectors the company operates in by country and region.
  • Detailed breakdowns of revenues and market share benchmarked against competitors.
  • Profiles of the pipeline of products that the company is developing.
  • Critical analysis of the company's strengths, weaknesses opportunities and threats and positioning on the value chain.
  • Provides summary analysis of key revenue lines and strategy.
  • Details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
  • Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

  • A single source to fulfill all of your business and competitor intelligence needs
  • Research your competitors' business structure, strategy and prospects.
  • Counter your competitors' strengths and target their weaknesses.
  • Identify your competitors' key revenue streams by market and geography.
  • Identify & assess potential corporate and investment opportunities
  • Support sales activities by understanding your customers' businesses better.
  • Identify potential competitor products before they reach market.
  • Qualify prospective partners and suppliers.

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What is this report about?
    • 2.2 Definitions
      • 2.2.1 Ophthalmic Devices
  • 3 Company Snapshot
    • 3.1 Key Information
    • 3.2 Company Overview
    • 3.3 Financial Performance
    • 3.4 SWOT Snapshot
  • 4 Business Description
    • 4.1 Business Overview
    • 4.2 Cataract and Vitreoretinal Surgery Product Category
      • 4.2.1 Overview
      • 4.2.2 Financials
    • 4.3 Contact Lenses Product Category
      • 4.3.1 Overview
      • 4.3.2 Financials
      • 4.3.3 Market View
    • 4.4 Lens Care Product Category
      • 4.4.1 Overview
      • 4.4.2 Financials
      • 4.4.3 Market View
      • 4.4.4 Key Strategies
    • 4.5 Pharmaceuticals Category
      • 4.5.1 Overview
      • 4.5.2 Financials
      • 4.5.3 Key Strategies
    • 4.6 Refractive Surgery Product Category
      • 4.6.1 Overview
      • 4.6.2 Financials
      • 4.6.3 Key Strategies
    • 4.7 Major Products and Services
      • 4.7.1 Overview
  • 5 History
  • 6 Business Strategy
    • 6.1 Mission Statement
    • 6.2 Strategy
    • 6.3 Corporate Social Responsibility
      • 6.3.1 Overview
      • 6.3.2 Specific CSR Initiatives
  • 7 Value Chain Analysis
    • 7.1 Manufacturing
      • 7.1.1 In House Manufacturing
      • 7.1.2 Outsourcing
    • 7.2 Product Development
      • 7.2.1 Regulatory Approvals
      • 7.2.2 Clinical Trials
      • 7.2.3 Research and Development
    • 7.3 Sales and Marketing
      • 7.3.1 Partnerships and Alliances
      • 7.3.2 Licensing Agreements
      • 7.3.3 E-distribution
  • 8 SWOT Analysis
    • 8.1 Overview
    • 8.2 Bausch & Lomb Incorporated Strengths
      • 8.2.1 Diversified global presence
      • 8.2.2 Comprehensive product portfolio
      • 8.2.3 Brand value
    • 8.3 Bausch & Lomb Incorporated Weaknesses
      • 8.3.1 Weak revenue growth
      • 8.3.2 Product recalls
      • 8.3.3 Low returns
    • 8.4 Bausch & Lomb Incorporated Opportunities
      • 8.4.1 Collaborations
      • 8.4.2 FDA approvals
      • 8.4.3 Emerging vitamin and nutrition market
    • 8.5 Bausch & Lomb Incorporated Threats
      • 8.5.1 FDA warning
      • 8.5.2 Stringent reimbursement policies
  • 9 Competitors
  • 10 Bausch & Lomb Incorporated Medical Equipment Market Share
    • 10.1 Bausch & Lomb Incorporated, Global, Market Share (2006)
    • 10.2 Bausch & Lomb Incorporated, APAC, Market Share (2006)
    • 10.3 Bausch & Lomb Incorporated, Europe, Market Share (2006)
    • 10.4 Bausch & Lomb Incorporated, MEA, Market Share (2006)
    • 10.5 Bausch & Lomb Incorporated, North America, Market Share (2006)
    • 10.6 Bausch & Lomb Incorporated, SCA, Market Share (2006)
  • 11 Revenue Analysis
    • 11.1 Revenue by Segment
    • 11.2 Revenue by Geography
  • 12 Financial and Operational Review
    • 12.1 Financial Statements
    • 12.2 Financial Ratios
  • 13 Share Holding Structure
  • 14 Key Employees
  • 15 Key Employee Biographies
  • 16 Locations And Subsidiaries
    • 16.1 Head Office
    • 16.2 Other Locations & Subsidiaries
  • 17 Financial Deals Landscape
    • 17.1 Bausch & Lomb Acquires eyeonics
    • 17.2 Warburg Pincus Acquires Bausch & Lomb
    • 17.3 Bausch & Lomb Completes Private Placement Of $650 Million
    • 17.4 Bausch & Lomb Acquires Soothe Emollient (Lubricant) Eye Drops From Alimera Sciences
    • 17.5 Bausch & Lomb Acquires Alimera's OTC Eye Care Product
    • 17.6 Bausch & Lomb Enters Into A Licensing Agreement With Schering AG
    • 17.7 Bayer HealthCare Signs An Agreement With Bausch & Lomb
    • 17.8 Bausch & Lomb Signs An Agreement With Cephalon
    • 17.9 Bausch & Lomb Signs An Agreement With PTC Therapeutics
    • 17.10 Bausch & Lomb Acquires Shandong Chia Tai Freda From Sino Biopharmaceutical
    • 17.11 CIBA Vision And Bausch & Lomb Enter Into Cross-License Agreement
    • 17.12 Advanced Medical Optics to acquire Bausch & Lomb
    • 17.13 Bausch & Lomb Forms A Strategic Alliance With Acufocus
  • 18 Recent Developments
    • 18.1 Mar 06, 2008: Bausch & Lomb Appoints CVP, CHRO
    • 18.2 Feb 05, 2008: Bausch & Lomb Appoints New Directors
    • 18.3 Jan 23, 2008: Bausch & Lomb Appoints New CEO
    • 18.4 Nov 20, 2007: Bausch & Lomb Appoints Corporate VP And General Counsel
    • 18.5 Aug 08, 2007: Bausch & Lomb Reports Q2 2007 Results
    • 18.6 Jul 24, 2007: Bausch & Lomb Declares Quarterly Dividend
    • 18.7 Jun 26, 2007: Bausch & Lomb Files Suit Against Alcon
    • 18.8 May 10, 2007: Bausch & Lomb Preliminary Q1 2007 Results
    • 18.9 May 01, 2007: Bausch & Lomb Declares Quarterly Dividend
    • 18.10 Mar 19, 2007: Bausch & Lomb Appoints New CFO
    • 18.11 Mar 19, 2007: Bausch & Lomb CFO Retires
    • 18.12 Mar 06, 2007: Bausch & Lomb Reports Preliminary Q4 And 2006 Results
    • 18.13 Feb 26, 2007: Bausch & Lomb Declares Quarterly Dividend
    • 18.14 Dec 22, 2006: Bausch & Lomb's Listing On NYSE Extended
    • 18.15 Nov 09, 2006: Bausch & Lomb Reports Preliminary Q3 2006 Results
    • 18.16 Nov 07, 2006: Bausch & Lomb Declares Quarterly Dividend
    • 18.17 Nov 06, 2006: Bausch & Lomb Receives FDA Warning Letter Related To Inspection At Greenville
    • 18.18 Jul 25, 2006: Bausch & Lomb Declares Quarterly Dividend
    • 18.19 May 02, 2006: Bausch & Lomb Declares Quarterly Dividend
    • 18.20 Apr 19, 2006: Bausch & Lomb Names New President For Its Asia Region
  • 19 Bausch & Lomb Incorporated Pipeline Products
    • 19.1 Safarazi Elliptical Accommodating IOL
      • 19.1.1 Product Overview
      • 19.1.2 Product Description
      • 19.1.3 Product Status
    • 19.2 Akreos AO Micro-Incision sub-2-mm lens
      • 19.2.1 Product Overview
      • 19.2.2 Product Description
      • 19.2.3 Product Status
    • 19.3 Boston Xo (Hexafocon A)
      • 19.3.1 Product Overview
      • 19.3.2 Product Description
      • 19.3.3 Product Status
      • 19.3.4 Clinical Trials
      • 19.3.5 Product Milestone
      • 19.3.6 Product Patent Details
    • 19.4 TECHNOLAS 217A Excimer Laser System
      • 19.4.1 Product Overview
      • 19.4.2 Product Description
      • 19.4.3 Product Status
      • 19.4.4 Clinical Trials
      • 19.4.5 Product Patent Details
    • 19.5 Phaco Needles
      • 19.5.1 Product Overview
      • 19.5.2 Product Description
      • 19.5.3 Product Status
      • 19.5.4 Product Patent Details
    • 19.6 New Generation Diagnostic Instrument
      • 19.6.1 Product Overview
      • 19.6.2 Product Description
      • 19.6.3 Product Status
      • 19.6.4 Clinical Trials
    • 19.7 Boston orthokeratology
      • 19.7.1 Product Overview
      • 19.7.2 Product Description
      • 19.7.3 Product Status
    • 19.8 SOFLENS Contact lens
      • 19.8.1 Product Overview
      • 19.8.2 Product Description
      • 19.8.3 Product Status
      • 19.8.4 Product Patent Details
    • 19.9 Akreos Single Use Insertion Device
      • 19.9.1 Product Overview
      • 19.9.2 Product Description
      • 19.9.3 Product Status
      • 19.9.4 Product Patent Details
    • 19.10 Ngx Microsurgical System
      • 19.10.1 Product Overview
      • 19.10.2 Product Description
      • 19.10.3 Product Status
      • 19.10.4 Product Milestone
      • 19.10.5 Product Patent Details
    • 19.11 Zyoptix XP Epi Separator
      • 19.11.1 Product Overview
      • 19.11.2 Product Description
      • 19.11.3 Product Status
      • 19.11.4 Product Milestone
      • 19.11.5 Product Patent Details
    • 19.12 SofLens daily disposable
      • 19.12.1 Product Overview
      • 19.12.2 Product Description
      • 19.12.3 Product Status
      • 19.12.4 Product Patent Details
    • 19.13 Sofport AO (LI61AO) Lens
      • 19.13.1 Product Overview
      • 19.13.2 Product Description
      • 19.13.3 Product Status
      • 19.13.4 Clinical Trials
      • 19.13.5 Product Patent Details
    • 19.14 PureVision Visibilty Tinted contact lenses
      • 19.14.1 Product Overview
      • 19.14.2 Product Description
      • 19.14.3 Product Status
      • 19.14.4 Product Milestone
      • 19.14.5 Product Patent Details
    • 19.15 PMMA Interocular Lens
      • 19.15.1 Product Overview
      • 19.15.2 Product Description
      • 19.15.3 Product Status
      • 19.15.4 Product Patent Details
    • 19.16 Boston X02 (hexafocon B)
      • 19.16.1 Product Overview
      • 19.16.2 Product Description
      • 19.16.3 Product Status
    • 19.17 BOSTON ES
      • 19.17.1 Product Overview
      • 19.17.2 Product Description
      • 19.17.3 Product Status
    • 19.18 The Millennium Advanced Flow System
      • 19.18.1 Product Overview
      • 19.18.2 Product Description
      • 19.18.3 Product Status
      • 19.18.4 Product Milestone
      • 19.18.5 Product Patent Details
    • 19.19 Venturi Phaco Packs
      • 19.19.1 Product Overview
      • 19.19.2 Product Description
      • 19.19.3 Product Status
      • 19.19.4 Product Milestone
    • 19.20 SofLens 66 Toric Contact Lenses
      • 19.20.1 Product Overview
      • 19.20.2 Product Description
      • 19.20.3 Product Status
      • 19.20.4 Product Milestone
      • 19.20.5 Product Patent Details
    • 19.21 BOSTON EQUALENS
      • 19.21.1 Product Overview
      • 19.21.2 Product Description
      • 19.21.3 Product Status
      • 19.21.4 Product Milestone
      • 19.21.5 Product Patent Details
    • 19.22 Boston SIMPLUS Multi-Action Solution
      • 19.22.1 Product Overview
      • 19.22.2 Product Description
      • 19.22.3 Product Status
      • 19.22.4 Product Patent Details
    • 19.23 ReNu MultiPlus Multi-Purpose Solution
      • 19.23.1 Product Overview
      • 19.23.2 Product Description
      • 19.23.3 Product Status
      • 19.23.4 Product Milestone
    • 19.24 OcuCoat
      • 19.24.1 Product Overview
      • 19.24.2 Product Description
      • 19.24.3 Product Status
      • 19.24.4 Clinical Trials
    • 19.25 Amvisc and Amvisc Plus
      • 19.25.1 Product Overview
      • 19.25.2 Product Description
      • 19.25.3 Product Status
      • 19.25.4 Clinical Trials
      • 19.25.5 Product Milestone
    • 19.26 Soflens Multi-Focal Contact Lenses
      • 19.26.1 Product Overview
      • 19.26.2 Product Description
      • 19.26.3 Product Status
      • 19.26.4 Product Patent Details
    • 19.27 PureVision Multi-Focal Contact Lenses
      • 19.27.1 Product Overview
      • 19.27.2 Product Description
      • 19.27.3 Product Status
      • 19.27.4 Clinical Trials
      • 19.27.5 Product Milestone
      • 19.27.6 Product Patent Details
    • 19.28 Proview Eye Pressure Monitor
      • 19.28.1 Product Overview
      • 19.28.2 Product Description
      • 19.28.3 Product Status
      • 19.28.4 Product Milestone
    • 19.29 Soflens oneday disposable contactlens
      • 19.29.1 Product Overview
      • 19.29.2 Product Description
      • 19.29.3 Product Status
      • 19.29.4 Product Milestone
      • 19.29.5 Product Patent Details
    • 19.30 PureVision Lenses for Therapeutic use
      • 19.30.1 Product Overview
      • 19.30.2 Product Description
      • 19.30.3 Product Status
      • 19.30.4 Product Milestone
      • 19.30.5 Product Patent Details
    • 19.31 Optima 38/SP
      • 19.31.1 Product Overview
      • 19.31.2 Product Description
      • 19.31.3 Product Status
    • 19.32 SofLens59 contact lenses
      • 19.32.1 Product Overview
      • 19.32.2 Product Description
      • 19.32.3 Product Status
    • 19.33 F3 Series Contact Lenses
      • 19.33.1 Product Overview
      • 19.33.2 Product Description
      • 19.33.3 Product Status
      • 19.33.4 Clinical Trials
      • 19.33.5 Product Patent Details
    • 19.34 SofLens38 Contact Lenses
      • 19.34.1 Product Overview
      • 19.34.2 Product Description
      • 19.34.3 Product Status
    • 19.35 Boston EO
      • 19.35.1 Product Overview
      • 19.35.2 Product Description
      • 19.35.3 Product Status
      • 19.35.4 Product Milestone
    • 19.36 Silsoft
      • 19.36.1 Product Overview
      • 19.36.2 Product Description
      • 19.36.3 Product Status
      • 19.36.4 Clinical Trials
      • 19.36.5 Product Patent Details
    • 19.37 Millennium TSV25 System
      • 19.37.1 Product Overview
      • 19.37.2 Product Description
      • 19.37.3 Product Milestone
    • 19.38 Zyoptix XP Microkeratome
      • 19.38.1 Product Overview
      • 19.38.2 Product Description
      • 19.38.3 Product Status
      • 19.38.4 Clinical Trials
      • 19.38.5 Product Milestone
      • 19.38.6 Product Patent Details
    • 19.39 Zyoptix diagnostic workstation
      • 19.39.1 Product Overview
      • 19.39.2 Product Description
      • 19.39.3 Product Status
    • 19.40 Hansatome Excellus Microkeratome
      • 19.40.1 Product Overview
      • 19.40.2 Product Description
      • 19.40.3 Product Status
      • 19.40.4 Product Milestone
      • 19.40.5 Product Patent Details
    • 19.41 Vitrasert Implant
      • 19.41.1 Product Overview
      • 19.41.2 Product Description
      • 19.41.3 Product Status
      • 19.41.4 Clinical Trials
      • 19.41.5 Product Milestone
      • 19.41.6 Product Patent Details
    • 19.42 Zywave II Wavefront Aberrometer
      • 19.42.1 Product Overview
      • 19.42.2 Product Description
      • 19.42.3 Product Milestone
    • 19.43 Orbscan IIz Corneal Topographer
      • 19.43.1 Product Overview
      • 19.43.2 Product Description
      • 19.43.3 Product Status
      • 19.43.4 Clinical Trials
      • 19.43.5 Product Milestone
      • 19.43.6 Product Patent Details
    • 19.44 High speed vitrectomy cutter
      • 19.44.1 Product Overview
      • 19.44.2 Product Description
      • 19.44.3 Product Status
      • 19.44.4 Product Milestone
      • 19.44.5 Product Patent Details
    • 19.45 ADATO SIL-ol 5000
      • 19.45.1 Product Overview
      • 19.45.2 Product Description
      • 19.45.3 Product Status
      • 19.45.4 Clinical Trials
    • 19.46 Austin Strut Caliper
      • 19.46.1 Product Overview
      • 19.46.2 Product Description
      • 19.46.3 Product Status
    • 19.47 Awh Backflush Handpiece Active/Passive
      • 19.47.1 Product Overview
      • 19.47.2 Product Description
      • 19.47.3 Product Status
      • 19.47.4 Product Patent Details
    • 19.48 Nike MAXSIGHT Sport-Tinted Contact Lens
      • 19.48.1 Product Overview
      • 19.48.2 Product Description
      • 19.48.3 Product Status
      • 19.48.4 Product Milestone
      • 19.48.5 Product Patent Details
    • 19.49 Optima Toric Contact Lenses
      • 19.49.1 Product Overview
      • 19.49.2 Product Description
      • 19.49.3 Product Status
      • 19.49.4 Product Patent Details
    • 19.50 H3/H4 Series Contact Lenses
      • 19.50.1 Product Overview
      • 19.50.2 Product Description
      • 19.50.3 Product Status
    • 19.51 Boston MultiVision Contact Lenses
      • 19.51.1 Product Overview
      • 19.51.2 Product Description
      • 19.51.3 Product Status
      • 19.51.4 Product Patent Details
    • 19.52 Sensitive Eyes Plus Saline Solution
      • 19.52.1 Product Overview
      • 19.52.2 Product Description
      • 19.52.3 Product Status
      • 19.52.4 Product Milestone
      • 19.52.5 Product Patent Details
    • 19.53 Sensitive Eyes Saline Solution
      • 19.53.1 Product Overview
      • 19.53.2 Product Description
      • 19.53.3 Product Status
      • 19.53.4 Product Milestone
      • 19.53.5 Product Patent Details
    • 19.54 Sensitive Eyes Daily Cleaner
      • 19.54.1 Product Overview
      • 19.54.2 Product Description
      • 19.54.3 Product Status
      • 19.54.4 Product Patent Details
    • 19.55 ReNu Leak Proof Lens Case
      • 19.55.1 Product Overview
      • 19.55.2 Product Description
      • 19.55.3 Product Status
    • 19.56 ReNu MultiPlus
      • 19.56.1 Product Overview
      • 19.56.2 Product Description
      • 19.56.3 Product Status
      • 19.56.4 Product Patent Details
    • 19.57 Meridian Acrylic Intraocular Lenses
      • 19.57.1 Product Overview
      • 19.57.2 Product Description
      • 19.57.3 Product Status
      • 19.57.4 Clinical Trials
      • 19.57.5 Product Milestone
      • 19.57.6 Product Patent Details
    • 19.58 Castroviejo Caliper
      • 19.58.1 Product Overview
      • 19.58.2 Product Description
    • 19.59 CyberCases
      • 19.59.1 Product Overview
      • 19.59.2 Product Description
      • 19.59.3 Product Status
    • 19.60 ERGOTEC Premiere Adaptor
      • 19.60.1 Product Overview
      • 19.60.2 Product Description
      • 19.60.3 Product Status
      • 19.60.4 Product Patent Details
    • 19.61 Barraquer Blade Breaker and Holder
      • 19.61.1 Product Overview
      • 19.61.2 Product Description
      • 19.61.3 Product Status
      • 19.61.4 Product Patent Details
    • 19.62 Storz IA hand pieces
      • 19.62.1 Product Overview
      • 19.62.2 Product Description
      • 19.62.3 Product Status
    • 19.63 Devgan Micro Capsulorhexis Forceps
      • 19.63.1 Product Overview
      • 19.63.2 Product Description
      • 19.63.3 Product Status
      • 19.63.4 Product Milestone
      • 19.63.5 Product Patent Details
    • 19.64 Devgan Lieberman Temporal Approach Lid Speculum
      • 19.64.1 Product Overview
      • 19.64.2 Product Description
      • 19.64.3 Product Status
      • 19.64.4 Product Patent Details
    • 19.65 Devgan-Seibel Fixation Ring
      • 19.65.1 Product Overview
      • 19.65.2 Product Description
      • 19.65.3 Product Status
      • 19.65.4 Product Patent Details
    • 19.66 Braga-Mele Hydrochop Cannula
      • 19.66.1 Product Overview
      • 19.66.2 Product Description
      • 19.66.3 Product Status
    • 19.67 Kavanagh Reversible Speculum
      • 19.67.1 Product Overview
      • 19.67.2 Product Description
      • 19.67.3 Product Status
      • 19.67.4 Product Milestone
    • 19.68 Mackool Cataract Support Hook
      • 19.68.1 Product Overview
      • 19.68.2 Product Description
      • 19.68.3 Product Status
    • 19.69 Osher Iris Retractor
      • 19.69.1 Product Overview
      • 19.69.2 Product Description
      • 19.69.3 Product Status
    • 19.70 Stellaris Vision Enhancement System
      • 19.70.1 Product Overview
      • 19.70.2 Product Description
      • 19.70.3 Product Status
      • 19.70.4 Product Milestone
    • 19.71 Hall Locking Inserter Forcep
      • 19.71.1 Product Overview
      • 19.71.2 Product Description
      • 19.71.3 Product Status
    • 19.72 Silicone Eye Sphere
      • 19.72.1 Product Overview
      • 19.72.2 Product Description
      • 19.72.3 Product Status
  • 20 Appendix
    • 20.1 Global Markets Direct Research Methodology
    • 20.2 Coverage
    • 20.3 Secondary Research
    • 20.4 Primary Research
    • 20.5 Models
    • 20.6 Forecasts
    • 20.7 Expert Panels
    • 20.8 Market Revenue Chapters
      • 20.8.1 Abbreviations
      • 20.8.2 Currency Conversions
    • 20.9 About Global Markets Direct
    • 20.10 Contact Us
    • 20.11 Disclaimer
  • List of Tables
    • Table 1: Bausch & Lomb Incorporated,Key Facts, 2006
    • Table 2: Bausch & Lomb Incorporated, SWOT Analysis, 2006
    • Table 3: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Global, Revenue ($ mn) and Market Share (%), 2006
    • Table 4: Bausch & Lomb Incorporated Ophthalmic Devices by Category, APAC, Revenue ($ mn) and Market Share (%), 2006
    • Table 5: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Australia, Revenue ($ mn) and Market Share (%), 2006
    • Table 6: Bausch & Lomb Incorporated Ophthalmic Devices by Category, China, Revenue ($ mn) and Market Share (%), 2006
    • Table 7: Bausch & Lomb Incorporated Ophthalmic Devices by Category, India, Revenue ($ mn) and Market Share (%), 2006
    • Table 8: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Japan, Revenue ($ mn) and Market Share (%), 2006
    • Table 9: Bausch & Lomb Incorporated Ophthalmic Devices by Category, New Zealand, Revenue ($ mn) and Market Share (%), 2006
    • Table 10: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Republic of Korea, Revenue ($ mn) and Market Share (%), 2006
    • Table 11: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Taiwan, Revenue ($ mn) and Market Share (%), 2006
    • Table 12: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Europe, Revenue ($ mn) and Market Share (%), 2006
    • Table 13: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Austria, Revenue ($ mn) and Market Share (%), 2006
    • Table 14: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Czech Republic, Revenue ($ mn) and Market Share (%), 2006
    • Table 15: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Finland, Revenue ($ mn) and Market Share (%), 2006
    • Table 16: Bausch & Lomb Incorporated Ophthalmic Devices by Category, France, Revenue ($ mn) and Market Share (%), 2006
    • Table 17: Bausch & Lomb Incorporated Diabetic Care Devices, Germany, Revenue ($ mn) and Market Share (%), 2006
    • Table 18: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Greece, Revenue ($ mn) and Market Share (%), 2006
    • Table 19: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Hungary, Revenue ($ mn) and Market Share (%), 2006
    • Table 20: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Ireland, Revenue ($ mn) and Market Share (%), 2006
    • Table 21: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Italy, Revenue ($ mn) and Market Share (%), 2006
    • Table 22: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Netherlands, Revenue ($ mn) and Market Share (%), 2006
    • Table 23: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Norway, Revenue ($ mn) and Market Share (%), 2006
    • Table 24: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Poland, Revenue ($ mn) and Market Share (%), 2006
    • Table 25: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Portugal, Revenue ($ mn) and Market Share (%), 2006
    • Table 26: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Russian Federation, Revenue ($ mn) and Market Share (%), 2006
    • Table 27: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Spain, Revenue ($ mn) and Market Share (%), 2006
    • Table 28: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Sweden, Revenue ($ mn) and Market Share (%), 2006
    • Table 29: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Switzerland, Revenue ($ mn) and Market Share (%), 2006
    • Table 30: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Turkey, Revenue ($ mn) and Market Share (%), 2006
    • Table 31: Bausch & Lomb Incorporated Ophthalmic Devices by Category, United Kingdom, Revenue ($ mn) and Market Share (%), 2006
    • Table 32: Bausch & Lomb Incorporated Ophthalmic Devices by Category, MEA, Revenue ($ mn) and Market Share (%), 2006
    • Table 33: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Egypt, Revenue ($ mn) and Market Share (%), 2006
    • Table 34: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Israel, Revenue ($ mn) and Market Share (%), 2006
    • Table 35: Bausch & Lomb Incorporated Ophthalmic Devices by Category, South Africa, Revenue ($ mn) and Market Share (%), 2006
    • Table 36: Bausch & Lomb Incorporated Ophthalmic Devices by Category, UAE, Revenue ($ mn) and Market Share (%), 2006
    • Table 37: Bausch & Lomb Incorporated Ophthalmic Devices by Category, North America, Revenue ($ mn) and Market Share (%), 2006
    • Table 38: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Canada, Revenue ($ mn) and Market Share (%), 2006
    • Table 39: Bausch & Lomb Incorporated Ophthalmic Devices by Category, United States, Revenue ($ mn) and Market Share (%), 2006
    • Table 40: Bausch & Lomb Incorporated Ophthalmic Devices by Category, SCA, Revenue ($ mn) and Market Share (%), 2006
    • Table 41: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Argentina, Revenue ($ mn) and Market Share (%), 2006
    • Table 42: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Brazil, Revenue ($ mn) and Market Share (%), 2006
    • Table 43: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Chile, Revenue ($ mn) and Market Share (%), 2006
    • Table 44: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Mexico, Revenue ($ mn) and Market Share (%), 2006
    • Table 45: Bausch & Lomb Incorporated, Revenue by Segment, USD Million, 2002-2006
    • Table 46: Bausch & Lomb Incorporated, Revenue by Geography, USD Million, 2002-2006
    • Table 47: Bausch & Lomb Incorporated, Financial Statements, USD Million, 2002-2006
    • Table 48: Bausch & Lomb Incorporated, Financial Ratios, USD Million, 2002-2006
    • Table 49: Bausch & Lomb Incorporated, Share Holding Structure
    • Table 50: Bausch & Lomb Incorporated,Key Employees, 2006
    • Table 51: Bausch & Lomb Incorporated, Other Locations
    • Table 52: Bausch & Lomb Incorporated, Other Locations(Contd.)
    • Table 53: Abbreviations used in the Market Revenue Chapters
    • Table 54: Currency Conversion used in the Market Revenue Chapters
  • List of Figures
    • Figure 1: Bausch & Lomb Incorporated, Value Chain Analysis
    • Figure 2: Bausch & Lomb Incorporated, Ophthalmic Device, Global, Category Revenue Share (%), 2006
    • Figure 3: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Global, Share of Market (%), 2006
    • Figure 4: Bausch & Lomb Incorporated Ophthalmic Device, APAC, Category Revenue Share (%), 2006
    • Figure 5: Bausch & Lomb Incorporated Ophthalmic Devices by Category, APAC, Share of Market (%), 2006
    • Figure 6: Bausch & Lomb Incorporated Ophthalmic Device, Australia, Category Revenue Share (%), 2006
    • Figure 7: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Australia, Share of Market (%), 2006
    • Figure 8: Bausch & Lomb Incorporated Ophthalmic Devices, China, Category Revenue Share (%), 2006
    • Figure 9: Bausch & Lomb Incorporated Ophthalmic Devices by Category, China, Share of Market (%), 2006
    • Figure 10: Bausch & Lomb Incorporated Ophthalmic Devices, India, Category Revenue Share (%), 2006
    • Figure 11: Bausch & Lomb Incorporated Ophthalmic Devices by Category, India, Share of Market (%), 2006
    • Figure 12: Bausch & Lomb Incorporated Ophthalmic Devices, Japan, Category Revenue Share (%), 2006
    • Figure 13: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Japan, Share of Market (%), 2006
    • Figure 14: Bausch & Lomb Incorporated Ophthalmic Devices, New Zealand, Category Revenue Share (%), 2006
    • Figure 15: Bausch & Lomb Incorporated Ophthalmic Devices by Category, New Zealand, Share of Market (%), 2006
    • Figure 16: Bausch & Lomb Incorporated Ophthalmic Devices, Republic of Korea, Category Revenue Share (%), 2006
    • Figure 17: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Republic of Korea, Share of Market (%), 2006
    • Figure 18: Bausch & Lomb Incorporated Ophthalmic Devices, Taiwan, Category Revenue Share (%), 2006
    • Figure 19: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Taiwan, Share of Market (%), 2006
    • Figure 20: Bausch & Lomb Incorporated Ophthalmic Devices, Europe, Category Revenue Share (%), 2006
    • Figure 21: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Europe, Share of Market (%), 2006
    • Figure 22: Bausch & Lomb Incorporated Ophthalmic Devices, Austria, Category Revenue Share (%), 2006
    • Figure 23: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Austria, Share of Market (%), 2006
    • Figure 24: Bausch & Lomb Incorporated Ophthalmic Devices, Belgium, Category Revenue Share (%), 2006
    • Figure 25: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Belgium, Share of Market (%), 2006
    • Figure 26: Bausch & Lomb Incorporated Ophthalmic Devices, Czech Republic, Revenue Share (%), 2006
    • Figure 27: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Czech Republic, Share of Market (%), 2006
    • Figure 28: Bausch & Lomb Incorporated Ophthalmic Devices, Finland, Category Revenue Share (%), 2006
    • Figure 29: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Finland, Share of Market (%), 2006
    • Figure 30: Bausch & Lomb Incorporated Ophthalmic Devices, France, Category Revenue Share (%), 2006
    • Figure 31: Bausch & Lomb Incorporated Ophthalmic Devices by Category, France, Share of Market (%), 2006
    • Figure 32: Bausch & Lomb Incorporated Ophthalmic Devices, Germany, Category Revenue Share (%), 2006
    • Figure 33: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Germany, Share of Market (%), 2006
    • Figure 34: Bausch & Lomb Incorporated Ophthalmic Devices, Greece, Category Revenue Share (%), 2006
    • Figure 35: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Greece, Share of Market (%), 2006
    • Figure 36: Bausch & Lomb Incorporated Ophthalmic Devices, Hungary, Category Revenue Share (%), 2006
    • Figure 37: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Hungary, Share of Market (%), 2006
    • Figure 38: Bausch & Lomb Incorporated Ophthalmic Devices, Ireland, Category Revenue Share (%), 2006
    • Figure 39: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Ireland, Share of Market (%), 2006
    • Figure 40: Bausch & Lomb Incorporated Ophthalmic Devices, Italy, Category Revenue Share (%), 2006
    • Figure 41: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Italy, Share of Market (%), 2006
    • Figure 42: Bausch & Lomb Incorporated Ophthalmic Devices, Netherlands, Category Revenue Share (%), 2006
    • Figure 43: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Netherlands, Share of Market (%), 2006
    • Figure 44: Bausch & Lomb Incorporated Ophthalmic Devices, Norway, Category Revenue Share (%), 2006
    • Figure 45: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Norway, Share of Market (%), 2006
    • Figure 46: Bausch & Lomb Incorporated Ophthalmic Devices, Poland, Category Revenue Share (%), 2006
    • Figure 47: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Poland, Share of Market (%), 2006
    • Figure 48: Bausch & Lomb Incorporated Ophthalmic Devices, Portugal, Category Revenue Share (%), 2006
    • Figure 49: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Portugal, Share of Market (%), 2006
    • Figure 50: Bausch & Lomb Incorporated Ophthalmic Devices, Russian Federation, Category Revenue Share (%), 2006
    • Figure 51: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Russian Federation, Share of Market (%), 2006
    • Figure 52: Bausch & Lomb Incorporated Ophthalmic Devices, Spain, Category Revenue Share (%), 2006
    • Figure 53: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Spain, Share of Market (%), 2006
    • Figure 54: Bausch & Lomb Incorporated Ophthalmic Devices, Sweden, Category Revenue Share (%), 2006
    • Figure 55: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Sweden, Share of Market (%), 2006
    • Figure 56: Bausch & Lomb Incorporated Ophthalmic Devices, Switzerland, Category Revenue Share (%), 2006
    • Figure 57: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Switzerland, Share of Market (%), 2006
    • Figure 58: Bausch & Lomb Incorporated Ophthalmic Devices, Turkey, Category Revenue Share (%), 2006
    • Figure 59: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Turkey, Share of Market (%), 2006
    • Figure 60: Bausch & Lomb Incorporated Ophthalmic Devices, United Kingdom, Category Revenue Share (%), 2006
    • Figure 61: Bausch & Lomb Incorporated Ophthalmic Devices by Category, United Kingdom, Share of Market (%), 2006
    • Figure 62: Bausch & Lomb Incorporated Ophthalmic Devices, MEA, Category Revenue Share (%), 2006
    • Figure 63: Bausch & Lomb Incorporated Ophthalmic Devices by Category, MEA, Share of Market (%), 2006
    • Figure 64: Bausch & Lomb Incorporated Ophthalmic Devices, Egypt, Category Revenue Share (%), 2006
    • Figure 65: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Egypt, Share of Market (%), 2006
    • Figure 66: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Israel, Share of Market (%), 2006
    • Figure 67: Bausch & Lomb Incorporated Ophthalmic Devices, South Africa, Category Revenue Share (%), 2006
    • Figure 68: Bausch & Lomb Incorporated Ophthalmic Devices by Category, South Africa, Share of Market (%), 2006
    • Figure 69: Bausch & Lomb Incorporated Ophthalmic Devices, UAE, Category Revenue Share (%), 2006
    • Figure 70: Bausch & Lomb Incorporated Ophthalmic Devices by Category, UAE, Share of Market (%), 2006
    • Figure 71: Bausch & Lomb Incorporated Ophthalmic Devices, North America, Category Revenue Share (%), 2006
    • Figure 72: Bausch & Lomb Incorporated Ophthalmic Devices by Category, North America, Share of Market (%), 2006
    • Figure 73: Bausch & Lomb Incorporated Ophthalmic Devices, Canada, Category Revenue Share (%), 2006
    • Figure 74: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Canada, Share of Market (%), 2006
    • Figure 75: Bausch & Lomb Incorporated Ophthalmic Devices, United States, Category Revenue Share (%), 2006
    • Figure 76: Bausch & Lomb Incorporated Ophthalmic Devices by Category, United States, Share of Market (%), 2006
    • Figure 77: Bausch & Lomb Incorporated Ophthalmic Devices, SCA, Category Revenue Share (%), 2006
    • Figure 78: Bausch & Lomb Incorporated Ophthalmic Devices by Category, SCA, Share of Market (%), 2006
    • Figure 79: Bausch & Lomb Incorporated Ophthalmic Devices, Argentina, Category Revenue Share (%), 2006
    • Figure 80: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Argentina, Share of Market (%), 2006
    • Figure 81: Bausch & Lomb Incorporated Ophthalmic Devices, Brazil, Category Revenue Share (%), 2006
    • Figure 82: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Brazil, Share of Market (%), 2006
    • Figure 83: Bausch & Lomb Incorporated Ophthalmic Devices, Chile, Category Revenue ($ mn) and Market Share (%), 2006
    • Figure 84: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Chile, Share of Market (%), 2006
    • Figure 85: Bausch & Lomb Incorporated Ophthalmic Devices, Mexico, Category Revenue Share (%), 2006
    • Figure 86: Bausch & Lomb Incorporated Ophthalmic Devices by Category, Mexico, Share of Market (%), 2006
    • Figure 87: Global Markets Direct Methodology
Product Features / Use
Scope Expert Insight/Opinion
Features Primary Research Data